BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1095 related articles for article (PubMed ID: 17227248)

  • 21. Prolongation of hemodialysis access survival with elective revision.
    Sands JJ; Miranda CL
    Clin Nephrol; 1995 Nov; 44(5):329-33. PubMed ID: 8605715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management.
    Ortega T; Ortega F; Diaz-Corte C; Rebollo P; Ma Baltar J; Alvarez-Grande J
    Nephrol Dial Transplant; 2005 Mar; 20(3):598-603. PubMed ID: 15647308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of survival of an expanded polytetrafluoroethylene graft designed for early cannulation to standard wall polytetrafluoroethylene grafts.
    Coyne DW; Lowell JA; Windus DW; Delmez JA; Shenoy S; Audrain J; Howard TK
    J Am Coll Surg; 1996 Oct; 183(4):401-5. PubMed ID: 8843271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter?
    Kaufman JL; Garb JL; Berman JA; Rhee SW; Norris MA; Friedmann P
    J Am Coll Surg; 1997 Jul; 185(1):74-9. PubMed ID: 9208965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study.
    Chan MR; Young HN; Becker YT; Yevzlin AS
    Semin Dial; 2008; 21(3):274-9. PubMed ID: 18397205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular access in patients treated with chronic hemodialysis for 30 years or more.
    Buturović-Ponikvar J; Persic V; Malovrh M; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):354-7. PubMed ID: 19695074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vascular access coordinator improves the prevalent fistula rate.
    Dwyer A; Shelton P; Brier M; Aronoff G
    Semin Dial; 2012; 25(2):239-43. PubMed ID: 21895771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTFE grafts versus tunneled cuffed catheters for hemodialysis: which is the second choice when arteriovenous fistula is not feasible?
    Donati G; Cianciolo G; Mauro R; Rucci P; Scrivo A; Marchetti A; Giampalma E; Golfieri R; Panicali L; Iorio M; Stella A; La Manna G; Stefoni S
    Artif Organs; 2015 Feb; 39(2):134-41. PubMed ID: 25205079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure.
    Wijnen E; Planken N; Keuter X; Kooman JP; Tordoir JH; de Haan MW; Leunissen KM; van der Sande F
    Nephrol Dial Transplant; 2006 Dec; 21(12):3514-9. PubMed ID: 16921189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular access for hemodialysis: the impact on morbidity and mortality.
    Di Iorio BR; Bellizzi V; Cillo N; Cirillo M; Avella F; Andreucci VE; De Santo NG
    J Nephrol; 2004; 17(1):19-25. PubMed ID: 15151255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular access for hemodialysis: experience of a team of nephrologists.
    Stanziale R; Lodi M; D'Andrea E; D'Andrea T
    Hemodial Int; 2008 Jul; 12(3):328-30. PubMed ID: 18638088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemoglobin level and vascular access survival in haemodialysis patients.
    Garrancho JM; Kirchgessner J; Arranz M; Klinkner G; Rentero R; Ayala JA; Marcelli D
    Nephrol Dial Transplant; 2005 Nov; 20(11):2453-7. PubMed ID: 16077146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
    Sajgure A; Choudhury A; Ahmed Z; Choudhury D
    Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multidisciplinary approach to hemodialysis vascular access at the Mount Sinai Hospital.
    Vassalotti JA; Falk A; Teodorescu V; Uribarri J
    Mt Sinai J Med; 2004 Mar; 71(2):94-102. PubMed ID: 15029401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis.
    Ohira S; Naito H; Amano I; Azuma N; Ikeda K; Kukita K; Goto Y; Sakai S; Shinzato T; Sugimoto T; Takemoto Y; Haruguchi H; Hino I; Hiranaka T; Mizuguchi J; Miyata A; Murotani N;
    Ther Apher Dial; 2006 Oct; 10(5):449-62. PubMed ID: 17096701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of low serum fetuin A levels with poor arteriovenous access patency in patients undergoing maintenance hemodialysis.
    Chen HY; Chiu YL; Chuang YF; Hsu SP; Pai MF; Lai CF; Yang JY; Peng YS; Tsai TJ; Wu KD
    Am J Kidney Dis; 2010 Oct; 56(4):720-7. PubMed ID: 20801568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distal vascular access for chronic hemodialysis in patients over 65 years of age. Surgical results].
    Cante P; Bottet P; Ryckelynck JP; Le Roch B; Levaltier B; Lobbedez T; Bensadoun H
    Prog Urol; 1998 Feb; 8(1):83-8. PubMed ID: 9533157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II).
    Mendelssohn DC; Ethier J; Elder SJ; Saran R; Port FK; Pisoni RL
    Nephrol Dial Transplant; 2006 Mar; 21(3):721-8. PubMed ID: 16311264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management.
    Kakkos SK; Haddad GK; Haddad JA; Scully MM
    Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):356-65. PubMed ID: 18603454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.